Clinical trial
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
NCT01337557 is registered in ClinicalTrials.gov with Hom, Milton M., OD, FAAO as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
- Lead sponsor
- Hom, Milton M., OD, FAAO
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2011
- Completion date
- November 30, 2011
- Enrollment
- 24 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allergic conjunctivitis